Tens of thousands of Albertans struggle with effective pain management daily. Managing pain is the most common reason people seek medical attention, and recently, has led to an over-reliance on opioid drugs, with Canada being the second highest consumer of these medications.
The impact of the recent legalization of cannabis has yet to be fully understood. Neuroscientists throughout Alberta are collaborating to research the potential applications of Cannabis use.
The Pain, Cannabis, Opioid program aims to:
- Improve pain management for Albertans
- Inform novel treatment and intervention for pain to the public
- Produce quality research to inform government policy
Campus Alberta Neuroscience welcomes any industry or research collaborations.
Campus Alberta Neuroscience is supporting the Alberta Pain Research Network to encourage collaborative research, improve patient care, train the next generation of pain scientists and clinicians, and shape government and clinical policy in the next three years.
The APRN is committed to bringing together pain researchers from across the province and gaining a better understanding of all the work currently underway from bench to the bedside. As a research community, we will identify our current gaps in pain-related research across Alberta.
Working groups are in the process of being formed and activities should commence in early 2021.
These groups will consists of individuals from across Alberta who are dedicated to improving pain research and interested in being part of our Working Groups. We are interested in pain across one’s lifespan – from birth through to end of life. Together, we will prioritize areas to create and improve knowledge and apply any learnings to the front line to improve clinical practice in five areas of research, including:
- Acute Pain
- Pain in Chronic Diseases
- Pediatric Pain
- Opioid and Non-Opioid Use in Pain Management
- Impact of Pain on Healthcare Delivery and Policy.
Contact the Pain, Cannabis, Opioid Program
For more information on the Pain, Cannabis, Opioid program, please contact Campus Alberta Neuroscience at (403) 220-2422 or [email protected].